A study to assess the prevalence of airflow obstruction and effect of bronchodilators and/ inhaled corticosteroids on Sleep and daily activity in patients with OSA and Undiagnosed Airflow Obstructio
Not Applicable
- Conditions
- Health Condition 1: null- Undiagnosed Obstructive pulmonary disease with Obstructive sleep apnea
- Registration Number
- CTRI/2018/04/013299
- Lead Sponsor
- Fortis Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age is >=40 years
2. Has given consent to inclusion in the study
3. Established on CPAP for at least 3 months
4. Obstructive Spirometry
Exclusion Criteria
1. History of Heart Failure
2. Known COPD/Asthma and on treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Incidence of airflow obstruction using 70% and 75% cut off. <br/ ><br>2) difference in CAT score and FOSQ between the two groups <br/ ><br>3) Activity Data (number of steps in a day) before and after LABA/LAMA <br/ ><br>4) change in CAT test after treatment in the two groups (70% and 75% cut off) <br/ ><br>5) change in FOSQ <br/ ><br>6) 6 minute walk test pre and post treatment <br/ ><br>Timepoint: 1) Incidence of airflow obstruction using 70% and 75% cut off. <br/ ><br>2) difference in CAT score and FOSQ between the two groups <br/ ><br>3) Activity Data (number of steps in a day) before and after LABA/LAMA <br/ ><br>4) change in CAT test after treatment in the two groups (70% and 75% cut off) <br/ ><br>5) change in FOSQ <br/ ><br>6) 6 minute walk test pre and post treatment <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Change in ESS, <br/ ><br>2.CPAP compliance <br/ ><br>Timepoint: One year